Howard Capital Management (New York)’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $24.6M | Sell |
175,004
-1,851
| -1% | -$261K | 2.76% | 13 |
|
|
2020
Q3 | $19.7M | Buy |
176,855
+1,155
| +0.7% | +$129K | 2.49% | 16 |
|
|
2020
Q2 | $19.7M | Buy |
175,700
+760
| +0.4% | +$85.1K | 2.62% | 11 |
|
|
2020
Q1 | $13.5M | Buy |
174,940
+2,630
| +2% | +$204K | 2.31% | 17 |
|
|
2019
Q4 | $16.4M | Buy |
172,310
+27,470
| +19% | +$2.61M | 2.05% | 19 |
|
|
2019
Q3 | $11M | Buy |
144,840
+7,900
| +6% | +$602K | 1.57% | 30 |
|
|
2019
Q2 | $12M | Buy |
136,940
+10,102
| +8% | +$886K | 1.64% | 31 |
|
|
2019
Q1 | $11.5M | Buy |
126,838
+44,611
| +54% | +$4.04M | 1.62% | 30 |
|
|
2018
Q4 | $5.9M | Sell |
82,227
-72,600
| -47% | -$5.21M | 0.97% | 37 |
|
|
2018
Q3 | $14.8M | Buy |
154,827
+3,780
| +3% | +$362K | 1.98% | 18 |
|
|
2018
Q2 | $14.4M | Buy |
151,047
+128,065
| +557% | +$12.2M | 2.07% | 20 |
|
|
2018
Q1 | $2.02M | Buy |
+22,982
| New | +$2.02M | 0.29% | 52 |
|
|
2017
Q3 | – | Sell |
-3,200
| Closed | -$247K | – | 113 |
|
|
2017
Q2 | $247K | Buy |
+3,200
| New | +$247K | 0.04% | 103 |
|